Episode 336: Which Patients Are Not Suitable for 1st Line EVP in Bladder Cancer?

Dr. Jonathan Rosenberg and a surprise guest discuss comorbidities and treatment-related side effects linked to the use of EV/pembro in bladder cancer, as well as the criteria needed to receive this treatment.